Diabetes and disease state management (DSM)
Type 2 diabetes is an escalating epidemic with predictions of
worldwide prevalence exceeding three million by 2030.1 There
is now irrefutable evidence that strict control of type 2 diabetes
can delay the onset of the complications of this disease,2 is costeffective,
and brings about improvements in overall quality of life.3,4
These findings highlight the need for disease state management
(DSM) approaches which focus on intensive management of type
2 diabetes involving regular monitoring, follow-up, and continuity of
care. Such approaches have been shown to be effective in improving
disease control in a recent meta-analysis of disease management
programmes